Complete disappearance of bone lesions with high dose chemotherapy supported with autologous stem cell transplantation in primary bone lymphoma

dc.contributor.authorSahin F.
dc.contributor.authorSimsir I.Y.
dc.contributor.authorErtan Y.
dc.contributor.authorSever A.
dc.contributor.authorBuyukkececi F.
dc.contributor.authorSaydam, G..
dc.date.accessioned2019-10-27T00:09:29Z
dc.date.available2019-10-27T00:09:29Z
dc.date.issued2006
dc.departmentEge Üniversitesien_US
dc.description.abstractPrimary bone lymphoma is a rare group of lymphomas. Histologically, the most common type of primary bone lymphoma is diffuse large cell type and of intermediate type. We present a case with primary bone lymphoma and treated with 8 cycles of CHOP regimen resulted with partial response with persisting bone lesions. High dose chemotherapy and autologous peripheral blood stem cell transplantation was performed two years after of diagnosis and, osteolytic lesions on the bones completely disappeared after this treatment. The patient is still in remission without any new bone events and with normal clinical and laboratory findings. Complete disappearance and durable complete remission of bone lesions in primary bone lymphoma is very rare, even after high dose chemotherapy. Copyright © Hellenic Society of Haematology.en_US
dc.identifier.endpage575en_US
dc.identifier.issn1108-2682
dc.identifier.issn1108-2682en_US
dc.identifier.issue4en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage572en_US
dc.identifier.urihttps://hdl.handle.net/11454/21692
dc.identifier.volume9en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.relation.ispartofHAEMAen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAutologous stem cell transplantationen_US
dc.subjectComplete remissionen_US
dc.subjectOsteolysisen_US
dc.subjectPrimary bone lymphomaen_US
dc.titleComplete disappearance of bone lesions with high dose chemotherapy supported with autologous stem cell transplantation in primary bone lymphomaen_US
dc.typeArticleen_US

Dosyalar